CONATUS PHARMACEUTICALS INC. Common Stock (par value $0.0001 per share) At Market Issuance Sales AgreementConatus Pharmaceuticals Inc. • August 14th, 2014 • Pharmaceutical preparations • New York
Company FiledAugust 14th, 2014 Industry JurisdictionConatus Pharmaceuticals Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with MLV & Co. LLC (“MLV”), as follows: